Brain function in social anxiety disorder

Psychiatric Clinics of North America

Volumn 24, Issue 4, 2001, Pages 707-722

  Argyropoulos, Spilios V ^a   Bell, Caroline J ^a   Nutt, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANXIETY NEUROSIS; BRAIN FUNCTION; DISEASE CLASSIFICATION; DOPAMINERGIC SYSTEM; HUMAN; MOTOR PERFORMANCE; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC NERVE CELL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0035158234     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70259-8     Document Type: Article

References (57)

1. The psychobiology of anxiolytic drugs: II. Pharmacological treatments of anxiety
2. Serotonin and panic
3. The neurobiology of social phobia
4. Social phobia: Diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment
5. 2 challenge test in patients with social phobia
6. An investigation into the psychobiology of social phobia: Personality domains and serotonergic function
7. A psychobiological model of temperament and character
8. Flumazenil challenge in social phobia
9. Magnetic resonance spectroscopy in social phobia: Preliminary results
10. Tryptophan depletion challenge in depressed patients treated with desipramine or fluoxetine: Implications for the role of serotonin in the mechanism of antidepressant action
11. The quest for biological correlates of social phobia: An interim assessment
12. Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy
13. Core symptom pattern of social phobia
14. D2 dopamine receptors and personality traits
15. 2 challenge test in anxiety disorder patients
16. DSM-III-R subtypes of social phobia: Comparison of generalised social phobics and public-speaking phobes
17. Serotonergic function in social phobia: Comparison to normal control and obsessive-compulsive disorder subjects
18. Effect of alcohol on social phobic anxiety
19. Abnormal peripheral benzodiazepine receptor density associated with generalised social phobia
20. Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies
21. Responses of "generalised" and "discrete" social phobics during public speaking
22. Specificity of lactate infusions in social phobia versus panic disorders
23. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls
24. PET studies in experimental and pathological anxiety
25. Neural correlates of anxiety provocation in social phobia
26. Decreased brain GABA-A benzodiazepine receptor binding in panic disorder: Preliminary results from a quantitative PET study
27. Brain mechanisms and circuits in panic disorder
28. Salivary cortisol levels in socially phobic adolescent girls
29. Response to alcohol in social phobia
30. Short stature, growth hormone deficiency, and social anxiety
31. Brain mechanisms of social anxiety disorder
32. Epinephrine infusions in patients with social phobia
33. Diagnostic and substance specificity of carbon dioxide induced panic
34. Magnetic resonance imaging in patients with social phobia
35. The neurobiology of social phobia
36. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia
37. 2 receptor binding potential in social phobia
38. Evidence for social phobia and other psychiatric disorders in adults who were growth hormone deficient during childhood
39. Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders
40. Lymphocyte β-adrenoreceptors in social phobia
41. Autonomic responsivity in generalized social phobia
42. 3H] Paroxetine binding to platelets of patients with social phobia: Comparison to patients with panic disorder and healthy volunteers
43. A brain single photon emission computed tomography (SPECT) study of generalised social phobia
44. Neurobiological perspectives on social phobia: From affiliation to zoology
45. The hypothalamic-pituitary-thyroid axis in social phobia
46. Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: A pilot study
47. Neurobiology of social phobia
48. Growth hormone response to intravenous clonidine in social phobia: Comparison to patients with panic disorder and healthy volunteers
49. Lactic acid response to caffeine in panic disorder: Comparison with social phobics and normal controls
50. Neuroendocrine responsivity to monoaminergic system probes in generalised social phobia
51. Dopamine reuptake site densities in patients with social phobia
52. A repeat proton magnetic resonance spectroscopy study in social phobia
53. Normal urinary free cortisol and postdexamethasone cortisol in social phobia: Comparison to normal volunteers
54. Functional brain imaging and pharmacotherapy in social phobia: Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram
55. Hormonal probes of central serotonergic activity: Do they really exist?
56. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls